<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03216694</url>
  </required_header>
  <id_info>
    <org_study_id>222793</org_study_id>
    <nct_id>NCT03216694</nct_id>
  </id_info>
  <brief_title>The Association Between Preoperative CPEX and Postoperative Morbidity Following Oesophagectomy</brief_title>
  <official_title>The Association Between Preoperative Cardiopulmonary Exercise Test Variables and Short-term Postoperative Morbidity Following Oesophagectomy: a Hospital-based Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of East Anglia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of East Anglia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective hospital-based cohort study of the association between preoperative
      cardiopulmonary exercise test (CPEX) variables and short-term postoperative morbidity
      following oesophagectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to examine the correlations between preoperative CPEX variables
      (VO2max and Anaerobic Threshold) and 30 day postoperative all cause morbidity in a sample
      large enough to allow (should significant associations exist) calculation of a threshold
      value. Secondary aims are to examine associations between the VO2max, AT and cardiopulmonary,
      non-cardiopulmonary complications as well as specific complications (atrial fibrillation,
      pneumonia, and anastomotic leak) as well as 30 and 90 day mortality.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 21, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">October 4, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause postoperative morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using Esophageal Complications Consensus Group (ECCG) definitions [1] and graded using Clavien-Dindo severity classification [2].</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary complications</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using ECCG definitions and graded using Clavien-Dindo severity classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-cardiopulmonary complications</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using ECCG definitions and graded using Clavien-Dindo severity classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>All cause mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>All cause mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using ECCG definitions and graded using Clavien-Dindo severity classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using ECCG definitions and graded using Clavien-Dindo severity classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomotic leak</measure>
    <time_frame>30 days</time_frame>
    <description>Classified using ECCG definitions and graded using Clavien-Dindo severity classification.</description>
  </secondary_outcome>
  <enrollment type="Actual">254</enrollment>
  <condition>Oesophageal Cancer</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiopulmonary exercise testing</intervention_name>
    <description>Aerobic fitness measured using a cycle ergometer and metabolic cart</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that underwent oeosphagectomy at the Norfolk and Norwich Hospital between
        September 2011 to March 2017
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        i. male and female ii. underwent an oesophagectomy iii. completed a pre-operative CPEX test

        Exclusion Criteria:

        i. patients that were unable to complete a full CPEX test ii. emergency or palliative
        surgery iii. pharyngolaryngo-oesophagectomy iv. oesophagectomy and gastrectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/25607756</url>
    <description>[1]</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/15273542</url>
    <description>[2]</description>
  </link>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 11, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2017</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

